Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events understanding critical element search alzheimer’s disease treatments
… for unresectable hepatocellular carcinoma (HCC) treatments: balancing overall survival and quality of life. Li D, Tan A, Hernandez S, Reilly N, Bussberg CJ , Mansfield C . Poster …
Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022) Share on: Wednesday, September 28 - Saturday, October 1, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the Tenth Annual Meeting …
… in the US Share on: April 5, 2023 Image Meningococcal disease is caused by the bacterium Neisseria meningitidis and … between patient and provider and barriers related to the understanding of financial reimbursement among healthcare …
… Neal J, Lee JB, Ahn MJ, Ariyasu R, Nash C, Smith D, Nagar S, Jimenez M , Kahangire DA, Kim YJ, Nasirova F, Lin S. Poster …
… Preferences for characteristics of oral antipsychotic treatments: survey results of patients living with … MJ, Boeri M, Vass C, Bussberg C, Panchmatia HR, Gasper S, Citrome L, Sajatovic M. Poster …
… of a global real-world study. Lin SH, Ahn M, Nagar S, Affi R, Agulnik J, Shih J, Hochmair MJ, Tufman A, …
Trends in the Inclusion of Patient Reported Outcomes in Oncology Clinical Trials Margaret Mordin, MS Vice President, Market Access and Outcomes Strategy RTI Health Solutions Trends in the inclusion of patient reported outcomes in oncology clinical trials: …
… communication channel that hasn’t existed before. For help understanding how to develop effective and appropriate …
… studies using common analyses to study responses to treatments in large populations. SIGMA executive committee … effects for the citizens of Europe.” The SIGMA Consortium’s VISION is to provide best evidence on the use, benefits and … Prof. Jesper Hallas, FISPE France University of Bordeaux’s Bordeaux PharmacoEpi Platform Prof. Nicholas Moore, FISPE …
… survey development and implementation; and a thorough understanding of the Food and Drug Administration (FDA) … expertise across a range of indications, including women’s health, hemophilia, rare disease, pediatric rare disease, pediatrics, Alzheimer’s disease, and movement disorders. Additionally, …